Better Coronavirus Stock: Eli Lilly or AbbVie?
Over the past several months, the coronavirus stock market has proven nerve-wracking for even the most seasoned of investors. We are living in unprecedented times. But the basic rules of investing haven't changed, and there are still worthwhile investment opportunities to be found.
Eli Lilly (NYSE: LLY) is a veteran in the pharmaceutical community and has been in business for over 140 years. AbbVie (NYSE: ABBV) is a relative newcomer and was established back in 2013 after spinning off parent organization Abbott Laboratories. Both companies have been resilient overall amid the tumult of the current recession. I would also add that each carries the possibility of strong returns for dividend investors with a long-term buying focus. But which is the better buy?
Image Source: Getty Images.
Source Fool.com
